Ling Yun Chen

US Patent:

7406090, Jul 29, 2008

Filed:

Jun 30, 2003

Appl. No.:

10/611616

Inventors:

Ling Chen - Livingston NJ, US

Assignee:

Intel Corporation - Santa Clara CA

International Classification:

G06F 12/00
G06F 13/00
H04L 12/54
H04J 3/06

US Classification:

370412, 3703954, 370413, 370415, 370417, 370419, 370428, 370509, 370512, 711147, 3794061

Abstract:

A method and apparatus to perform buffer management for media processing are described.

US Patent:

7655762, Feb 2, 2010

Filed:

Jan 6, 2006

Appl. No.:

11/327844

Inventors:

Gregory M. Landes - The Woodlands TX, US
Kyu Chung - Granger IN, US
Ling Chen - Blue Bell PA, US
Urvi Desai - The Woodlands TX, US
David Reed Powell - Houston TX, US
Seokjoo Hong - The Woodlands TX, US

Assignee:

Lexicon Pharmaceuticals, Inc. - The Woodlands TX

International Classification:

C07K 16/18

US Classification:

5303881, 5303879

Abstract:

Monoclonal antibodies that specifically bind to ANGPTL4 are provided. Monoclonal antibodies that neutralize at least one activity of ANGPTL4 are provided. Methods of treating a disorder of lipid metabolism using neutralizing monoclonal antibodies are provided.

US Patent:

7865634, Jan 4, 2011

Filed:

Jun 30, 2008

Appl. No.:

12/164902

Inventors:

Ling Chen - Livingston NJ, US

Assignee:

Intel Corporation - Santa Clara CA

International Classification:

G06F 12/00
G06F 13/00
H04L 12/54
H04J 3/06

US Classification:

710 52, 710 54, 710 55, 711147, 3703954, 370412, 370413, 370415, 370417, 370419, 370428, 370509, 370512, 3794061

Abstract:

A method and apparatus to perform buffer management for media processing are described.

US Patent:

8092796, Jan 10, 2012

Filed:

Dec 4, 2009

Appl. No.:

12/631598

Inventors:

Gregory M. Landes - The Woodlands TX, US
Kyu Chung - Granger IN, US
Ling Chen - Blue Bell PA, US
Urvi Desai - The Woodlands TX, US
David Reed Powell - Houston TX, US
Seokjoo Hong - The Woodlands TX, US

Assignee:

Lexicon Pharmaceuticals, Inc. - The Woodlands TX

International Classification:

C07K 16/18
A61K 39/395

US Classification:

4241301, 5303879, 5303881, 4241391, 4241411, 4241421, 4241331

Abstract:

Monoclonal antibodies that specifically bind to ANGPTL4 are provided. Monoclonal antibodies that neutralize at least one activity of ANGPTL4 are provided. Methods of treating a disorder of lipid metabolism using neutralizing monoclonal antibodies are provided.

US Patent:

8559466, Oct 15, 2013

Filed:

Sep 28, 2004

Appl. No.:

10/952071

Inventors:

Kai X. Miao - Boonton Township NJ, US
Siu H. Lam - Woodcliff Lake NJ, US
Ling Chen - Livingston NJ, US

Assignee:

Intel Corporation - Santa Clara CA

International Classification:

H04J 3/16

US Classification:

370516, 370394, 370229, 370352, 370232, 370235, 370252

Abstract:

A method includes receiving at a receiver a voice signal in the form of a sequence of data packets, and using an automatic level control (ALC) component of the receiver to detect that one of the received packets is a silence packet or a noise packet. The method further includes receiving at a jitter delay control circuit from the ALC component a signal or signals to indicate that the one of the received packets is a silence or a noise packet, and dropping the one of the received packets in response to the signal or signals received from the ALC component. The ALC component includes a gain adjustment block and a level estimation and active voice detector block. The gain adjustment block is controlled by the level estimation and active voice detector block to adjust a gain applied by the gain adjustment block to an audio signal.

US Patent:

8591891, Nov 26, 2013

Filed:

Dec 8, 2011

Appl. No.:

13/315027

Inventors:

Gregory M. Landes - The Woodlands TX, US
Kyu Chung - Granger IN, US
Ling Chen - Blue Bell PA, US
Urvi Desai - The Woodlands TX, US
David Reed Powell - Houston TX, US
Seokjoo Hong - The Woodlands TX, US

Assignee:

Lexicon Pharmaceuticals, Inc. - The Woodlands TX

International Classification:

A61K 39/395
C07K 16/18

US Classification:

4241301, 4241391, 4241411, 4241421, 4241331, 5303879, 5303881

Abstract:

Monoclonal antibodies that specifically bind to ANGPTL4 are provided. Monoclonal antibodies that neutralize at least one activity of ANGPTL4 are provided. Methods of treating a disorder of lipid metabolism using neutralizing monoclonal antibodies are provided.

US Patent:

20030204551, Oct 30, 2003

Filed:

Apr 30, 2002

Appl. No.:

10/134760

Inventors:

Ling Chen - Livingston NJ, US

International Classification:

G06F009/00

US Classification:

709/102000

Abstract:

A system for providing a plurality of media processing services includes a processor and a computer-readable medium. The computer-readable medium has stored thereon a set of instructions to be executed by the processor to control multiple media processing services as separate state machines, with the same set of instructions controlling each of the media processing services.

US Patent:

20040010330, Jan 15, 2004

Filed:

Jul 11, 2002

Appl. No.:

10/192547

Inventors:

Ling Chen - Livingston NJ, US

International Classification:

G06F017/00

US Classification:

700/094000

Abstract:

A method for providing playback speed control of digital audio frames for multiple time slots over multiple of channels includes determining a maximum number of frames that can be processed during each of the time slots for all of the channels. The method further includes calculating a speed change determination for each time slot, the speed change determination specifying a total amount of frames that are processed during the time slots in order to achieve a desired speed change. The method further includes tracking an overload for each of the time slots as each of the channels is processed; and, as each of the channels are processed and for each time slot, generating a number of frames that is substantially equal to the speed determination for each time slot if the overload is substantially less than the determined maximum number of frames, or generating a number of frames as if no desired speed change is requested if the overhead is substantially greater than the determined maximum number of frames.